SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728889-08-000181
Filing Date
2008-02-05
Accepted
2008-02-04 18:22:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 INITIAL SCHEDULE 13G form13g.htm SC 13G 16336
  Complete submission text file 0000728889-08-000181.txt   18735
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 08573640
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6803 SOUTH TUCSON WAY N/A CENTENNIAL CO 80112-3924
Business Address 6803 SOUTH TUCSON WAY N/A CENTENNIAL CO 80112-3924 303-768-3200
OPPENHEIMER FUNDS INC (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000